2019
DOI: 10.1016/j.soard.2019.08.465
|View full text |Cite
|
Sign up to set email alerts
|

A527 Will GLP-1 Agonists shift the paradigm of surgical therapy in the fight against diabetes and obesity?

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles